Sign Language Instruction for Deafness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method of teaching sign language, called Strategic and Interactive Signing Instruction (SISI), to help deaf children in prekindergarten through 3rd grade improve their sign language skills. Teachers will be divided into two groups: one will use the SISI method, while the other will continue with their usual techniques. The goal is to determine if SISI can better support the language development of these children. Deaf children in prekindergarten to 3rd grade and their teachers in deaf education programs may be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative educational methods that could enhance language skills for young deaf children.
Will I have to stop taking my current medications?
The trial does not specify whether participants need to stop taking their current medications.
What prior data suggests that this method is safe for supporting sign language development in deaf children?
Research has shown that Strategic and Interactive Signing Instruction (SISI) can enhance sign language skills, potentially improving reading and health outcomes for deaf children. While specific safety data for this type of sign language teaching is not available, the trial does not involve testing a drug or medical device, so physical safety concerns remain minimal. The study focuses on learning and educational growth, making it a low-risk activity. Participants can feel assured that this study involves learning and support without any known negative effects.12345
Why are researchers excited about this trial?
Researchers are excited about the Strategic and Interactive Signing Instruction (SISI) because it offers a fresh approach to teaching sign language to deaf children. Unlike traditional methods, which may rely heavily on standard teaching practices, SISI emphasizes interactive and strategic instruction tailored to enhance children's sign language skills more effectively. This innovative approach could lead to better language development outcomes, providing educators and students with a more engaging and potentially more effective learning experience.
What evidence suggests that Strategic and Interactive Signing Instruction is effective for sign language development in deaf children?
This trial will compare Strategic and Interactive Signing Instruction (SISI) with standard teaching methods. Studies have shown that learning complex sign language skills can improve reading and writing abilities and may even lead to better health. SISI resembles techniques that have successfully helped deaf and hard-of-hearing students enhance their writing and language skills. Research on a similar program, Strategic and Interactive Writing Instruction (SIWI), showed it effectively enhanced writing skills like storytelling and persuasive writing. These positive results suggest that SISI could help develop sign language skills in deaf children.12678
Who Is on the Research Team?
Leala Holcomb, PhD
Principal Investigator
Center of Deafness
Are You a Good Fit for This Trial?
This trial is for deaf children in prekindergarten to 3rd grade and their teachers. The study aims to include those involved in deaf education programs, specifically targeting educators teaching these grades.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-assessment
Pre-assessments conducted for all deaf children at the beginning of the school year
Treatment
Teachers in the experimental group receive SISI training and implement the framework; control group continues with regular methods
Post-assessment
Post-assessments conducted for all deaf children at the end of the school year
Follow-up
Participants are monitored for language development outcomes after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- Strategic and Interactive Signing Instruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator